Skip to content

wheat germ and oat cakes in gestational diabetes

The effect of wheat germ and oat enriched cakes on blood glucose,lipidemic parameters and liver enzymes in women with gestational diabetes referred to Motahari health care center, Shiraz 1396

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20171227038107N1
Enrollment
81
Registered
2018-01-04
Start date
2017-08-31
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gestational diabetes. Gestational diabetes mellitus in pregnancy, diet controlled

Interventions

Intervention 1: Intervention group: wheat germ enriched cake one per day for 8 weeks. Intervention 2: Intervention group: oat enriched cake one per day for 8 weeks. Intervention 3: Control group: ordi
Treatment - Other
Intervention group: wheat germ enriched cake one per day for 8 weeks
Intervention group: oat enriched cake one per day for 8 weeks
Control group: ordinary cake one per day for 8 weeks

Sponsors

Shiraz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: Inclination to participate in the study Lack of smoking and alcohol Confirmation of gestational diabetes mellitus with routine testing Singleton pregnancy Pregnant women between 18 to 40 years old

Exclusion criteria

Exclusion criteria: Women with insulin-dependent gestational diabetes Pair discontinuities and membrane premature rupture Occurrence of preeclampsia and hypothyroidism and urinary tract infection smokers Patients with liver or kidney disease People receiving estrogen medications Unwillingness to continue the study People who need insulin therapy during the study Failure to follow the intervention designed for study (no use of assigned cake for a total of less than 80% predicted or more than 3 consecutive days)

Design outcomes

Primary

MeasureTime frame
Fbs. Timepoint: Before the experiment, eight weeks after intervention. Method of measurement: Standard enzymatic method - milligrams per deciliter.;2hfpg. Timepoint: Before the experiment, eight weeks after intervention. Method of measurement: standard enzymatic method - milligrams per deciliter.;HBA1c. Timepoint: Before the experiment, eight weeks after intervention. Method of measurement: Standard enzymatic method - percentage.;TG. Timepoint: Before the experiment, eight weeks after intervention. Method of measurement: Standard enzymatic method - milligrams per deciliter.;TC. Timepoint: Before the experiment, eight weeks after intervention. Method of measurement: Standard enzymatic method - milligrams per deciliter.;LDL. Timepoint: Before the experiment, eight weeks after intervention. Method of measurement: Standard enzymatic method - milligrams per deciliter.;HDL. Timepoint: Before the experiment, eight weeks after intervention. Method of measurement: Standard enzymatic method - milligrams per deciliter.;AST. Timepoint: Before the experiment, eight weeks after intervention. Method of measurement: Standard enzymatic method - milligrams per deciliter.;ALT. Timepoint: Before the experiment, eight weeks after intervention. Method of measurement: Standard enzymatic method - milligrams per deciliter.;Weight. Timepoint: Before the experiment, eight weeks after intervention. Method of measurement: Balance - kg.;Systolic and diastolic blood pressure. Timepoint: Before the experiment, eight weeks after intervention. Method of measurement: Pressure set manually - mm Hg.

Secondary

MeasureTime frame
BMI. Timepoint: Before and after intervention. Method of measurement: weight devide into height2.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactArmaghan Shabeigi

Shiraz University of Medical Sciences

armaghan.shabeigi71@gmail.com+98 71 3725 1001

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026